FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used in treating endometriosis. Presented is the use of PARP inhibitors as a drug for normalizing cell metabolism of the female reproductive system in treating endometriosis.
EFFECT: invention provides normalization of mitochondrial function of pathological cells involved in development of endometriosis.
1 cl, 3 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
DRUG FOR TREATING ENDOMETRIOSIS | 2022 |
|
RU2818816C1 |
METHOD FOR CREATING CELL MODEL OF PREMATURE OVARIAN FAILURE IN WISTAR RATS | 2023 |
|
RU2815539C1 |
DIAGNOSTIC TECHNIQUE FOR HEREDITARY OPTIC NEUROPATHY | 2014 |
|
RU2566271C9 |
COMBINATION OF SIROSINGOPIN AND MITOCHONDRIAL INHIBITORS FOR TREATMENT OF CANCER AND FOR IMMUNOSUPPRESSION | 2012 |
|
RU2602937C2 |
AGENT FOR TREATING PARKINSON'S DISEASE | 2024 |
|
RU2839611C1 |
7-HYDROXYCOUMARIN DERIVATIVE FOR INDUCING MITOPHAGY IN CELLS, METHOD FOR PRODUCTION AND USE THEREOF | 2022 |
|
RU2819611C1 |
NONIMMUNOSUPPRESSIVE CYCLOSPORINE FOR TREATING CONGENITAL ULLRICH MYOPATHY | 2008 |
|
RU2462262C2 |
METHOD FOR SELECTING MITOCHONDRIA FOR EXPERIMENTAL THERAPY OF B16-F10 MELANOMA | 2022 |
|
RU2794762C1 |
NUCLEIC ACID FOR ALLOTOPIC EXPRESSION OF MT-ND4 GENE | 2023 |
|
RU2809065C1 |
MITOCHONDRIAL LOCALIZATION PEPTIDE, NUCLEIC ACID FOR ALLOTOPIC EXPRESSION OF MT-ND4 GENE CONTAINING ITS EXPRESSION VECTOR AND ITS USE | 2023 |
|
RU2817420C1 |
Authors
Dates
2025-04-29—Published
2024-03-19—Filed